Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe

Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe

Abstract Background A multi-centre field trial was conducted to evaluate the efficacy of afoxolaner based chewables (NexGard® or NexGard Spectra®) for the treatment of generalised demodicosis caused by Demodex canis in dogs under field conditions in France, Italy and Poland. Methods Client-owned dog...

Full description

Bibliographic Details
Main Authors: Wilfried Lebon, Massimo Beccati, Patrick Bourdeau, Thomas Brement, Vincent Bruet, Agnieszka Cekiera, Odile Crosaz, Céline Darmon, Jacques Guillot, Marion Mosca, Didier Pin, Jaroslaw Popiel, Dorota Pomorska Handwerker, Diane Larsen, Eric Tielemans, Frédéric Beugnet, Lénaïg Halos
Format: Article
Language:English
Published: BMC 2018-09-01
Series:Parasites & Vectors
Subjects:
Demodex canis
Generalised demodicosis
Mite
Dog
NexGard®
NexGard Spectra®
Online Access:http://link.springer.com/article/10.1186/s13071-018-3083-2

Internet

http://link.springer.com/article/10.1186/s13071-018-3083-2

Similar Items